Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.64 USD | -0.78% | +3.39% | +201.65% |
05-20 | Transcript : Jasper Therapeutics, Inc. - Special Call | |
05-13 | Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+201.65% | 359M | |
+38.09% | 728B | |
+32.43% | 603B | |
-5.14% | 360B | |
+20.16% | 332B | |
+1.85% | 279B | |
+16.06% | 244B | |
+8.00% | 207B | |
-5.60% | 205B | |
+5.96% | 164B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Jasper Therapeutics : Shares Soar Midday After Initiated by Oppenheimer With Outperform Rating, $21 Price Target